Food and Healthcare Press Releases th-TH Fri, 18 Jan 2019 9:57:10 +0700 Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems Ascensia Diabetes Care today announced it has entered into a global alliance with Zhejiang POCTech, Co., Ltd (POCTech), a developer and manufacturer of continuous glucose monitoring (CGM) systems. (Logo: Tue, 08 Jan 2019 13:03:57 +0700 MGI Announces Milestone of 1,000 Sequencers Installed and Opens Early Access Program for Groundbreaking Ultra-High-Throughput Sequencer, MGISEQ-T7 MGI, established in 2016 as a subsidiary of global genomics leader BGI Group, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries. MGI Chief Operating Officer Dr. Hui Jiang also announced the availability of MGI#s Tue, 08 Jan 2019 8:20:53 +0700 Gift of Life Donor Program is U.S. Leader in Saving Lives For the 11th consecutive year, Gift of Life Donor Program is the nation#s leading organ procurement organization (OPO), coordinating the most life-saving organs for transplant among all 58 U.S. OPOs. Gift of Life broke two national records in 2018, Mon, 07 Jan 2019 9:21:51 +0700 Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat Licensing rights are worldwide excluding US, Canada, Japan and South AmericaHelsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwide, today Mon, 24 Dec 2018 15:26:34 +0700 Childs Heartbeat Controls London Christmas Lights to Help Charity, Tiny Tickers London#s shopping streets, the Seven Dials, located in the heart of the West End, will celebrate Christmas Lights with a difference this December. See the stunning video here: (Photo: Mon, 24 Dec 2018 10:58:14 +0700 Merck and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer Merck and Pfizer Inc. (NYSE: PFE) today announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study of avelumab* did not support the study#s initial hypothesis, and therefore the alliance made the decision to terminate Mon, 24 Dec 2018 8:40:00 +0700 POLYTECH Health Aesthetics GmbH - Quality Made in Germany Pays Off: CE Approval For Breast Implants From One of the International Leading Companies Currently Confirmed On December 18, 2018, POLYTECH sold the three millionth implant since its establishment in 1986. The company is the only German manufacturer and present in over 75 countries worldwide. All implants are manufactured in the company#s own production Fri, 21 Dec 2018 8:34:59 +0700 Merck Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon - Agreement enables Merck to maintain an investment in the rapidly advancing oncology field of CAR-T, while focusing its RD efforts - Intrexon to issue Merck $150 million of Intrexon stock and a $25 million convertible Intrexon to receive a Fri, 21 Dec 2018 8:28:21 +0700 Lipofilling, Expanded Stem Cells Are a Valuable Alternative to Breast Implants Autologous adipose-derived stem cells (ADSCs) expansion avoids fat resorption, allowing to maintain results achieved after fat grafting 4 years follow-up results of Bioscience Institute Liposkill Plus body shaping approach presented at Las Vegas Easy Wed, 19 Dec 2018 9:00:00 +0700 BioNet reports on persistence of antibody responses of recombinant pertussis vaccines in the Lancet Infectious Diseases Publications report the sustained higher antibody responses of BioNet acellular pertussis vaccines containing genetically inactivated pertussis toxin (PTgen) and the new opportunities to control the resurgence of whooping cough disease BioNet announced Mon, 17 Dec 2018 13:09:48 +0700 The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization - Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections - The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in Thu, 13 Dec 2018 7:32:02 +0700 Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer - FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive Tue, 11 Dec 2018 8:00:25 +0700 Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities - Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include Fri, 07 Dec 2018 11:25:57 +0700 Vitality-linked Insurers to Get 100 million People 20% More Active by 2025 Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World Fri, 07 Dec 2018 9:20:46 +0700 World Congress of Cardiology Cardiovascular Health 2018 Opens in Dubai - Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact Thu, 06 Dec 2018 10:19:42 +0700 Data Presented at 2nd Healthy Lung Summit 2018 to Demonstrate Impact of AstraZeneca#s Healthy Lung Partnership Programme Deepening commitment to drive improvements for patients with respiratory disease across Asia, AstraZeneca with Business Sweden, The Swedish Trade Invest Council in Taiwan, hosts the second Healthy Lung Summit, ahead of the 2018 Asia Pacific Society Tue, 04 Dec 2018 8:00:00 +0700 Encore Medical Education Will Publish the Best of SABCS(R) News From 2018 San Antonio Breast Cancer Symposium (SABCS) Encore Medical Education will publish the Best of SABCS(R) News highlighting the key findings presented at the 41st San Antonio Breast Cancer Symposium (SABCS(R)), to be held on December 4-8, 2018 in San Antonio, Texas, USA. The Best of SABCS(R) News Mon, 03 Dec 2018 14:58:44 +0700 Herbalife Nutrition Survey Reveals Less than Half of Thais Aware of the Need to Take Active Steps Towards Healthy Aging Early, Ranking Second-Last in APAC Herbalife Nutrition Survey Reveals Less than Half of Thais Aware of the Need to Take Active Steps Towards Healthy Aging Early, Ranking Second-Last in APAC Herbalife Nutrition, a premier global nutrition company whose purpose is to make the world Thu, 29 Nov 2018 10:20:37 +0700 American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 diabetes and established cardiovascular disease in new Expert Consensus Decision Pathway A new Expert Consensus Decision Pathway issued by the American College of Cardiology (ACC) recommends empagliflozin as the preferred SGLT2 inhibitor for its proven benefit in reducing the risk of cardiovascular death in adults with type 2 diabetes and Tue, 27 Nov 2018 14:00:31 +0700 Medical Device Manufacturer Advant Medical Celebrates Its 25th Anniversary Advant is a successful medical device manufacturer with corporate offices located in Galway, Ireland. For a quarter of a century, Advant has seen significant growth and development expanding into two locations in Ireland, Mexico and Costa Rica. With over Wed, 21 Nov 2018 10:32:35 +0700 Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Board LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate#s Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in Tue, 20 Nov 2018 8:00:00 +0700 Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the Tue, 20 Nov 2018 8:00:00 +0700 APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025 - Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and Mon, 19 Nov 2018 8:57:29 +0700